id paper:paper_00257680_v67_nSUPPL2_p25_Ilarregui
record_format dspace
spelling paper:paper_00257680_v67_nSUPPL2_p25_Ilarregui2023-06-08T14:53:38Z Integrating the universe of regulatory cells in cancer. A major hurdle for successful immunotherapy Cancer Immunosuppression Myeloid-derived suppressor cells NKT cells Regulatory T cells Tolerogenic dendritic cells Tumor-immune escape CD11b antigen CD4 antigen gamma interferon interleukin 10 interleukin 12 interleukin 2 receptor alpha interleukin 23 tumor antigen article cancer cell cancer immunotherapy cell maturation cell population cell type dendritic cell disease model effector cell human immune deficiency immune response immune system immunocompetent cell immunostimulation malignant neoplastic disease medical research microenvironment natural killer T cell plasma cell regulatory T lymphocyte suppressor cell T lymphocyte tumor associated leukocyte tumor rejection 2007 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v67_nSUPPL2_p25_Ilarregui http://hdl.handle.net/20.500.12110/paper_00257680_v67_nSUPPL2_p25_Ilarregui
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Cancer
Immunosuppression
Myeloid-derived suppressor cells
NKT cells
Regulatory T cells
Tolerogenic dendritic cells
Tumor-immune escape
CD11b antigen
CD4 antigen
gamma interferon
interleukin 10
interleukin 12
interleukin 2 receptor alpha
interleukin 23
tumor antigen
article
cancer cell
cancer immunotherapy
cell maturation
cell population
cell type
dendritic cell
disease model
effector cell
human
immune deficiency
immune response
immune system
immunocompetent cell
immunostimulation
malignant neoplastic disease
medical research
microenvironment
natural killer T cell
plasma cell
regulatory T lymphocyte
suppressor cell
T lymphocyte
tumor associated leukocyte
tumor rejection
spellingShingle Cancer
Immunosuppression
Myeloid-derived suppressor cells
NKT cells
Regulatory T cells
Tolerogenic dendritic cells
Tumor-immune escape
CD11b antigen
CD4 antigen
gamma interferon
interleukin 10
interleukin 12
interleukin 2 receptor alpha
interleukin 23
tumor antigen
article
cancer cell
cancer immunotherapy
cell maturation
cell population
cell type
dendritic cell
disease model
effector cell
human
immune deficiency
immune response
immune system
immunocompetent cell
immunostimulation
malignant neoplastic disease
medical research
microenvironment
natural killer T cell
plasma cell
regulatory T lymphocyte
suppressor cell
T lymphocyte
tumor associated leukocyte
tumor rejection
Integrating the universe of regulatory cells in cancer. A major hurdle for successful immunotherapy
topic_facet Cancer
Immunosuppression
Myeloid-derived suppressor cells
NKT cells
Regulatory T cells
Tolerogenic dendritic cells
Tumor-immune escape
CD11b antigen
CD4 antigen
gamma interferon
interleukin 10
interleukin 12
interleukin 2 receptor alpha
interleukin 23
tumor antigen
article
cancer cell
cancer immunotherapy
cell maturation
cell population
cell type
dendritic cell
disease model
effector cell
human
immune deficiency
immune response
immune system
immunocompetent cell
immunostimulation
malignant neoplastic disease
medical research
microenvironment
natural killer T cell
plasma cell
regulatory T lymphocyte
suppressor cell
T lymphocyte
tumor associated leukocyte
tumor rejection
title Integrating the universe of regulatory cells in cancer. A major hurdle for successful immunotherapy
title_short Integrating the universe of regulatory cells in cancer. A major hurdle for successful immunotherapy
title_full Integrating the universe of regulatory cells in cancer. A major hurdle for successful immunotherapy
title_fullStr Integrating the universe of regulatory cells in cancer. A major hurdle for successful immunotherapy
title_full_unstemmed Integrating the universe of regulatory cells in cancer. A major hurdle for successful immunotherapy
title_sort integrating the universe of regulatory cells in cancer. a major hurdle for successful immunotherapy
publishDate 2007
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v67_nSUPPL2_p25_Ilarregui
http://hdl.handle.net/20.500.12110/paper_00257680_v67_nSUPPL2_p25_Ilarregui
_version_ 1768544073208037376